Show source-provided references
1. Pokropivny, V., Lohmus, R., Hussainova, I., Pokropivny, A., and Vlassov, S. (2007). Introduction to Nanomaterials and Nanotechnology, University of Tartu.
4. Mirkin, C.A., Meade, T.J., Petrosko, S.H., and Stegh, A.H. (2015). Nanotechnology-Based Precision Tools for the Detection and Treatment of Cancer, Springer.
10.1007/978-3-319-16555-4 ↗11. Wong, W.K., Guerra Liberal, F.D., and McMahon, S.J. (2022). DNA repair inhibitors potentiate fractionated radiotherapy more than single-dose radiotherapy in breast cancer cells. Cancers, 14.
10.3390/cancers14153794 ↗12. Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma
10.1186/s12943-023-01839-2 ↗13. Quantitative single-cell comparison of sensitization to radiation and a radiomimetic drug for diverse gold nanoparticle coatings
10.1002/smsc.202400053 ↗14. Norquest, C.J., Rogic, A., Gimotty, P.A., Maitz, C.A., Rindt, H., Ashworth, H.L., Bryan, J.N., Donnelly, L.L., McCleary-Wheeler, A.L., and Flesner, B.K. (2024). Effects of neoadjuvant zoledronate and radiation therapy on cell survival, cell cycle distribution, and clinical status in canine osteosarcoma. Front. Vet. Sci., 11.
10.3389/fvets.2024.1237084 ↗15. Understanding radiation response and cell cycle variation in brain tumour cells using Raman spectroscopy
10.1039/D3AN00121K ↗16. An NIR Discrete Metallacycle constructed from Perylene Bisimide and Tetraphenylethylene Fluorophores for imaging-guided cancer Radio-chemotherapy
10.1002/adma.202106388 ↗17. The Schemes, Mechanisms and Molecular Pathway Changes of Tumor Treating Fields (TTFields) Alone or in Combination with Radiotherapy and Chemotherapy
10.1038/s41420-022-01206-y ↗18. Therapeutic Potentials of Resveratrol in Combination with Radiotherapy and Chemotherapy during Glioblastoma Treatment: A Mechanistic Review
10.1186/s12935-021-02099-0 ↗19. WEE1 Kinase Limits CDK Activities to Safeguard DNA Replication and Mitotic Entry
23. Overcoming radioresistance with the hypoxia-activated prodrug CP-506: A pre-clinical study of local tumour control probability
10.1016/j.radonc.2023.109738 ↗24. Combining radiotherapy with targeted therapies in non-small cell lung cancer: Focus on anti-EGFR, anti-ALK and anti-angiogenic agents
10.21037/tlcr-20-552 ↗26. Zheng, Y., and Sanche, L. (2023). Mechanisms of nanoscale radiation enhancement by metal nanoparticles: Role of low energy electrons. Int. J. Mol. Sci., 24.
10.3390/ijms24054697 ↗27. Villalobos Gutiérrez, P.T., Muñoz Carrillo, J.L., Sandoval Salazar, C., Viveros Paredes, J.M., and Gutiérrez Coronado, O. (2023). Functionalized metal nanoparticles in cancer therapy. Pharmaceutics, 15.
10.20944/preprints202306.1125.v1 ↗31. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS
33. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine
10.1016/j.addr.2019.05.012 ↗36. Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking
10.7150/thno.5366 ↗38. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions
10.1002/jbm.a.36550 ↗40. Current trends in silica based drug delivery systems
42. Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy (Adv. Healthcare Mater. 26/2023)
10.1002/adhm.202370157 ↗43. Chen, X., Xu, Z., Li, T., Thakur, A., Wen, Y., Zhang, K., Liu, Y., Liang, Q., Liu, W., and Qin, J.J. (2024). Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy. Biomark. Res., 12.
10.1186/s40364-023-00551-z ↗44. Nanomaterial-based detection of circulating tumor cells and circulating cancer stem cells for cancer immunotherapy
10.1186/s40580-024-00466-x ↗45. Aljabali, A.A., Obeid, M.A., Gammoh, O., El-Tanani, M., Mishra, V., Mishra, Y., Kapre, S., Srivatsa Palakurthi, S., Hassan, S.S., and Nawn, D. (2024). Nanomaterial-driven precision immunomodulation: A new paradigm in therapeutic interventions. Cancers, 16.
10.3390/cancers16112030 ↗47. Han, J., Zhao, D., Li, D., Wang, X., Jin, Z., and Zhao, K. (2018). Polymer-based nanomaterials and applications for vaccines and drugs. Polymers, 10.
10.3390/polym10010031 ↗48. Metal-based nanomaterials in biomedical applications: Antimicrobial activity and cytotoxicity aspects
10.1002/adfm.201910021 ↗49. Recent progress on asymmetric carbon-and silica-based nanomaterials: From synthetic strategies to their applications
10.1007/s40820-021-00789-y ↗54. Temperature-responsive smart nanocarriers for delivery of therapeutic agents: Applications and recent advances
10.1021/acsami.6b00371 ↗57. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy
10.1016/j.jconrel.2014.12.008 ↗